Press Releases

You Narrowed By: Business/Product Release

Showing 1-35 of 115


2014

April

April 14

Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes

April 10

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

2013

December

December 17

A Space Age View into Human Vision: Abbott's iDesign Dx System Now Available for U.S. Ophthalmologists and Patients
 

November

November 27

Abbott Issues Voluntary Recall of Certain FreeStyle® and FreeStyle Lite® Blood Glucose Test Strips in the United States

November 7

Similac® Partners with National Association of Hispanic Nurses® to Launch StrongMoms® Español
 

October

October 30

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

October 25

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

October 18

New Study Demonstrates Importance of Oral Nutritional Supplements in Helping Hospitals Achieve Medicare Readmission Reduction Requirements

October 11

New Study Shows Oral Nutritional Supplement Use in Pediatric Inpatients Is Associated with Decreases in Length of Hospital Stay, Costs
 

September

September 17

Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™
 

August

August 30

Oral Nutritional Supplements in the Hospital Demonstrate Significant Health and Cost Benefits in New Research

August 21

Abbott Completes Acquisition of IDEV Technologies

August 19

Abbott Completes Acquisition of OptiMedica

August 15

Abbott Partners with Music Saves Lives® to Encourage Young Donors to Give the Gift of Blood
 

July

July 30

New Data for Abbott’s Investigational High Sensitive Troponin Test Shows It May Help Doctors Predict Heart Attack Risk

July 29

Abbott Features Solutions to Help Labs Prepare for the Evolving Healthcare Landscape at the American Association for Clinical Chemistry Lab Expo

July 25

Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and β–Ketone Monitoring System™

July 15

Abbott to Enter Laser Cataract Surgery Market through Acquisition of OptiMedica

July 15

Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio

July 10

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan
 

June

June 20

Abbott Announces New Test to Help Doctors Determine Personalized Treatment Path for Patients with Hepatitis C

June 11

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

June 4

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 3

Abbott Previews Next-Generation Blood Screening Prototype during International Society of Blood Transfusion Meeting
 

May

May 21

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 9

Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes

May 7

New Parenting Survey Reveals That Nearly All Moms Feel Judged on Parenting Decisions
 

April

April 18

Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients

April 16

Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand

April 15

Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States

April 10

Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient
 

March

March 28

New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues

March 20

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 11

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 10

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery